Live Chat
Send Offline Message

Suhagra 100

Suhagra 100
Availability: In Stock
Price: USD $28.00
* Packages:

Rating : 1 reviews

Generic Viagra

The manufacturer of Suhagra 100 medicine is Cipla. The medicine is composed of Sildenafil Citrate is the main active ingredient. There is no significant difference between them and the ingredients which are the same. The medicine helps repeated penile failure issue in man.

Suhagra 100 is also available in various combinations. The pill is prescribed for treating erectile dysfunction. The main active component in the medicine blocks enzyme phosphodiesterase-PDE5. The action of the pill depends on Sildenafil which makes the blood flow to the penile and as a result, a man has a stiffer erection. Such ingredients help in relaxing arteries in the penile and they might help for enhancing the flow of blood leading to stiffer penile while sexual stimulation.

The most popular treatment of ED is Suhagra 100. Sildenafil Citrate is to be consumed approx. 30 minutes to an hour before planned lovemaking session. You might take the tablet up to 4 hours before planned lovemaking session. For most of the patients, the recommended dose is 100 m, which has to be consumed as needed, approx. 1 hour before planned lovemaking session. Based on effectiveness and toleration of this individual patient, the dosage might be enhanced in increased to a maximum recommended dose of 100 mg. Sildenafil Citrate is not supposed to be consumed for more than once per day.

Some less common side effects of Suhagra 100 by Cipla which may occur are temporary changes in color vision (like trouble telling the difference between blue and green objects or having a blue color tinge to them), eyes being more sensitive to light, or blurred vision. These mild effects are nothing to worry about as they vanish soon.


Write a review

Your Name:

Your Review: Note: HTML is not translated!

Rating: Bad            Good

Enter the code in the box below:

Live Chat
Send Offline Message
Logos and trademarks remain the property of the corresponding companies. © 2019